EU-PRODUCT_SAFETY-ART_2
EU-PRODUCT_SAFETY-ART_2
General Product Safety Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of General Product Safety Directive (2001/95/EC), 15 January 2002, amended by Reg 596/2009/EC, 18 July 2009
This list contains a non-exhaustive inventory of substances that fall within the European Union's hazardous substance definitions, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; (2) Annex III of Directive 2000/54/EC (Biological Agents); Candidate List of SVHCs; and REACH Annexes XIV and XVII (Authorisation and Restriction lists). They can be considered hazardous for purposes of the General Product Safety Directive 2001/95/EC.
Last updated 26 april 2024. Database contains 5503 unique substances/entries.
Filter the list
|
915-270-3
|
-
|
yes |
yes |
||||
|
939-460-0
|
1471311-26-8
|
yes |
yes |
||||
|
939-460-0
|
1471311-26-8
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
X4261
|
401-850-9
|
255881-94-8
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
68583-35-7
|
B Bacteria and similar species |
|||||
|
-
|
-
|
yes |
Annex 17 Appendix 2; Annex 17 Appendix 4 |
||||
|
-
|
-
|
yes |
|||||
|
209-030-0
|
553-00-4
|
Annex 17 Appendix 1; Annex 17 Appendix 12 |
|||||
|
277-822-3
|
74332-73-3
|
Annex 17 Appendix 2 |
|||||
|
265-293-1
|
64969-34-2
|
Annex 17 Appendix 2 |
|||||
|
210-323-0
|
612-83-9
|
Annex 17 Appendix 2 |
|||||
|
-
|
-
|
Annex 17 Appendix 2 |
|||||
|
-
|
-
|
yes |
|||||
|
show/hide
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
1310480-27-3
Gamma-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
EC / List no:
-
| CAS no:
1329995-69-8
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. With pyrrolidine (1:1)
EC / List no:
-
| CAS no:
1187817-57-7
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, scandium(3+) salt (3:1)
EC / List no:
-
| CAS no:
350836-93-0
Sulfonium, tris[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
425670-70-8
Sulfonium, [4-[(2-methyl-1-oxo-2-propenyl)oxy]phenyl]diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1), polymer with 2-ethyltricyclo[3.3.1.13,7]dec-2-yl 2-methyl-2-propenoate, 3-hydroxytricyclo[3.3.1.13,7]dec-1-yl 2-methyl-2-propenoate and tetrahydro-2-oxo-3-furanyl 2-methyl-2-propenoate
EC / List no:
-
| CAS no:
911027-69-5
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd.with 2-methyl-2-propanamine (1:1)
EC / List no:
-
| CAS no:
202189-84-2
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, cesium salt (1:1)
EC / List no:
-
| CAS no:
92011-17-1
Quinolinium, 1-(carboxymethyl)-4-[2-[4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydrocyclopent[b]indol-7-yl]ethenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
1462414-59-0
Tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1)
EC / List no:
274-462-9
| CAS no:
70225-16-0
Dibenzo[k,n][1,4,7,10,13]tetraoxathiacyclopentadecinium, 19-[4-(1,1-dimethylethyl)phenyl]-6,7,9,10,12,13-hexahydro-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
928049-42-7
Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
1310480-24-0
Sulfonium, (thiodi-4,1-phenylene)bis[diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:2)
EC / List no:
-
| CAS no:
421555-73-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, yttrium(3+) salt (3:1)
EC / List no:
-
| CAS no:
41242-12-0
Beta-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
EC / List no:
-
| CAS no:
1329995-45-0
Sulfonium, [4-[(2-methyl-1-oxo-2-propen-1-yl)oxy]phenyl]diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
911027-68-4
Iodonium, diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
153443-35-7
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, lithium salt (1:1)
EC / List no:
-
| CAS no:
55120-77-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, neodymium(3+) salt (3:1)
EC / List no:
-
| CAS no:
41184-65-0
Sulfonium, (4-methylphenyl)diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
910606-39-2
Sulfonium, triphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
144116-10-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with N,N-diethylethanamine (1:1)
EC / List no:
-
| CAS no:
72033-41-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt
EC / List no:
-
| CAS no:
70136-72-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, gallium salt (9CI)
EC / List no:
-
| CAS no:
341035-71-0
Iodonium, bis[4-(1,1-dimethylpropyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic
EC / List no:
-
| CAS no:
421555-74-0
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(phenylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
1310480-28-4
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, sodium salt
EC / List no:
-
| CAS no:
82382-12-5
Iodonium, bis[(1,1-dimethylethyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) (9CI)
EC / List no:
-
| CAS no:
866621-50-3
Iodonium, bis[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
213740-81-9
Phosphonium, triphenyl(phenylmethyl)-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
1000597-52-3
Methanaminium, N,N,N-trimethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1)
EC / List no:
-
| CAS no:
189274-31-5
Sulfonium, bis(4-methylphenyl)phenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
EC / List no:
-
| CAS no:
341548-85-4
|
-
|
-
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
F Fungi |
|||||
|
-
|
-
|
F Fungi |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||